key: cord-1036527-ygjoo772
authors: Bignon, Emmanuelle; Monari, Antonio
title: Unraveling the Enzymatic Mechanism of the SARS-CoV-2 RNA-Dependent-RNA-Polymerase. An Unusual Active Site Leading to High Replication Rates
date: 2022-02-03
journal: bioRxiv
DOI: 10.1101/2022.02.02.478873
sha: 69c38dc4cd926bc1e830956f39afc856d683c432
doc_id: 1036527
cord_uid: ygjoo772

Viral infection relies on the hijacking of cellular machineries to enforce the reproduction of the infecting virus and its subsequent diffusion. In this context the replication of the viral genome is a key step performed by specific enzymes, i.e. polymerases. The replication of SARS-CoV-2, the causative agent of the COVID-19 pandemics, is based on the duplication of its RNA genome, an action performed by the viral RNA-dependent-RNA polymerase. In this contribution, for the first time and by using two-dimensional enhanced sampling quantum mechanics/ molecular mechanics, we have determined the chemical mechanisms leading to the inclusion of a nucleotide in the nascent viral RNA strand. We prove the high efficiency of the polymerase, which lowers the activation free energy to less than 10 kcal/mol. Furthermore, the SARS-CoV-2 polymerase active site is slightly different from those found usually found in other similar enzymes, and particularly it lacks the possibility to enforce a proton shuttle via a nearby histidine. Our simulations show that this absence is partially compensate by lysine, whose proton assist the reaction opening up an alternative, but highly efficient, reactive channel. Our results present the first mechanistic resolution of SARS-CoV-2 genome replication and shed light on unusual enzymatic reactivity paving the way for future rational design of antivirals targeting emerging RNA viruses.

The emergence of a new β−coronavirus, observed for the first time at the end of 2019 in Wuhan, China, has led to the sudden outbreak of the COVID-19 pandemic. [1] [2] [3] [4] [5] By the beginning of 2022, COVID-19 has affected almost all the continents, and has pushed public governments to implement severe containment and social distancing measures, seriously affecting economic and social life. The novel β−coronavirus has been recognized as the causative agent of a severe acute respiratory stress (SARS) and thus named SARS-CoV-2, to point out its similarity with SARS-CoV whose outbreak dated back to 2003. SARS-CoV-2 also shares structural and phylogenetic analogy with the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) emerged in 2012. Differently from its predecessors, SARS-CoV-2 has a lower mortality ratio (estimated at around 2-3 %) [6] [7] [8] and in some cases it develops asymptomatically, especially for its latest B.1.1.519 (omicron) variant. [9] [10] [11] However, its high contagiousness and the possible development of severe outcomes, especially in elder patients or subjects presenting comorbidities, has caused and still causes an impressive stress on the health systems, only mitigated by the development of novel vaccines also including the messenger RNA (mRNA) strategy. [12] [13] [14] As all β−coronaviruses, SARS-CoV-2 is an enveloped, rather large, positive-sense RNA virus. 15 As such its genetic material is contained inside a virion protected by a lipid membrane, and is constituted by a positive 5' to 3' single-stranded RNA consisting of about 30,000 nucleobases. 16 Upon infection the viral genetic material is injected into the cells where it hijacks the cellular machinery to enforce the production of viral proteins before initiating its replication. The analysis of SARS-CoV-2 transcriptome 17 shows that in addition to structural proteins, including the highly celebrated Spike protein, 18 which form the viral envelope and allow the interactions with human receptors, 19, 20 two large polyproteins are expressed and self-cleaved by the two viral enzymes, i.e. the 3CL-like (3CL P RO ) and the papaine-like (PL P RO ) proteases. [21] [22] [23] This leads to the maturation of several nonstructural proteins (NSP) which exert different (enzymatic) functions allowing SARS-CoV-2 to complete its maturation and assembly into novel virions, while also eluding the innate cellular immune system. Among those the RNA-dependent-RNA-polymerase (RNAP), composed of the complex NSP12/NSP7, is of particular importance. 24, 25 It uses the original viral positive-sense RNA strand to produce an intermediate negative-sense strand which is further used as a template allowing the synthesis of a novel duplicated positive-sense RNA strand. Of note, the RNA replication takes place in the cytoplasm in double-membrane vesicles and differently from other RNA viruses, SARS-CoV-2 also disposes of a replication proof-reading system based on a viral exonuclease, 26, 27 which limits replication errors and considerably slows down its mutation rate. Obviously SARS-CoV-2 RNAP constitutes an ideal target for possible pharmacological development., [28] [29] [30] Its inhibition would, indeed, result in the arrest of the viral replication cycle and of the infection. As a matter of fact, some nucleotide analogous, 29,30 also used against some retroviruses such as Human Immunodeficiency Virus (HIV), have been proposed for SARS-CoV-2 treatment and while they have shown interesting in vitro and in vivo efficiency their clinical use is strongly limited also by rather sever side-effects and a non-trivial pharmacokinetic and administration. Between the proposed nucleotide analogous inhibiting SARS-CoV-2, we may cite Remdesivir, 31 acting by impeding the RNA translocation, 32 which follows the inclusion of a new nucleotide to free the active site and slide along the template, and Favipiravir, 33,34 which instead directly inhibits the RNAP catalytic site. 35 While the structure of SARS-CoV-2 RNAP has been resolved, 24, 35 also in presence of inhibitors, the studies focusing on the enzymatic mechanism from a molecular and biochemical point of view are rare. Yet, the precise characterization of the rate limiting steps of the enzymatic process, together with the identification of the structures of the key intermediates and transition states would be of invaluable help in the design of efficient inhibitors. Figure 1 : A) Representative structure extracted from the classical MD simulation of the RNAP (blue) interacting with a RNA double-strand (red) composed of the template and the nascent strand. A zoom of the active site is also provided highlighting GTP, the Mg +2 4 cluster, and key protein residues such as K551. B) Sequence of the RNA strand used consistently for all the simulation. C) proposed chemical mechanisms for the inclusion of GTP on the nascent RNA strand.

From a chemical standpoint, polymerases are metalloenzymes, sharing many structural and chemical similarities with exo-and endonucleases. Their active site is usually constituted by a bimetallic Mg +4 2 cluster which is stabilized by the interaction with hard electron donors such as the anionic oxygen atoms of aspartates ( Figure 1 ). Furthermore, the presence of histidine residues which in addition to enhance the stabilization of the bimetallic cluster may also participate in proton shuttle completing the catalytic cycle, is also widely conserved and appears as fundamental. 36 Furthermore, and upon reactive conformations, the Mg +4 2 cluster is also interacting with the 3' oxygen of the nascent nucleic acid strand (3') and with the triphosphate form of the incorporating nucleotide. The selectivity and replication accuracy are assured by the fact that the triphosphate reactant nucleotide is Watson and Crick paired with the complementary base on the template strand. It is generally accepted that the 3' OH group of the nascent strand is easily deprotonated, also thanks to its activation provided by Mg 

All classical molecular dynamics (MD) simulations were carried on using NAMD. 37 Visualization, rendering of MD trajectories and plots were performed using the VMD, 41

Gnuplot and RStudio softwares.

The starting structure was generated from the crystal structure of SARS-CoV-2 RNAdependent RNA polymerase complexed with the Favipiravir inhibitor (PDB ID 7AAP).

The Favipiravir moiety was in silico mutated to the reactive Guanine Triphosphate (GTP),

keeping the catalytic magnesium ions as positioned in the crystal structure. As we chose to focus on the reaction step involving the attack of the deprotonated 3' terminal nucleotide (rU9) of the synthesized RNA strand, the O3' was coherently kept deprotonated. Force field parameters of the 3' deprotonated uracil were generated following the antechamber protocol -as described in Supplementary Materials. The system was then soaked into a TIP3P 42 water box with a 10Å buffer and potassium ions to ensure a neutral global charge, resulting in a total of ∼ 181,000 atoms. The ff14SB force field including the OL3 corrections 43 for RNA were used to describe the protein and the nucleic acid. RNAP presents a zinc fingers which has been modeled using non-bonded parameters. 44 The protonation states of the protein residues were assigned with respect to the pKa prediction made with propka3.1. 45 Of note, a cysteine near to the active site (C622) was considered as deprotonated for it is involved in the coordination of the magnesium cluster.

Hydrogen Mass Repartitioning (HMR) 46 was consistently applied to all hydrogens excluding water, thus allowing, in combination with Rattle and Shake, ? the use of a 4 fs time-step to numerically solve the Newton equations of motion. Prior to the simulation, the system geometry was optimized in four 10,000 steps with gradually decreasing restraints on the backbone atoms of the protein and RNA. Each of these steps was followed by a short 1.2 ns equilibration with the same restraints in order to ensure a proper relaxation of the system.

A 150 ns production run was then performed at 300K in the isotherm and isobaric (NTP) ensemble. The temperature was kept constant using the Langevin thermostat with a 1 ps −1 collision frequency, and the electrostatic interaction were treated using the Particle Mesh Ewald (PME) 47 scheme with a 9Å cutoff. A 10 kcal/mol constraint was imposed on the distance between the magnesium ions forming the cluster to compensate for the electrostatic repulsion and maintain the bimetallic active site in a pre-reactive conformation.

Structural analysis was performed using the cpptraj module of AMBER and the Curves+ program. 48 A clustering of the trajectory was performed to extract the most abundant conformation sampled as starting structure for the subsequent QM/MM-MD simulations.

The representative frame of the most populated cluster issued from classical MD simulations was taken as a starting point for the QM/MM approach. The QM partition was defined to encompass the triphosphate moiety and C5' atom of the GTP, the C2', C4' and C3' the 3' uracil (rU9), the magnesium ions, and the K551, K798, D760, D761, D618, C622 residuessee Figure S1 for a representation of the QM partition. All the involved amino acids were truncated at the Cα position, resulting in a total of 81 atoms described at the QM level with a total charge of -3 and in a singlet spin state. The rest of the system was described The consistence of the WHAM2D procedure was confirmed by checking the proper overlap between the windows as shown in Figure 2 . 

The structural dynamic behavior of the RNAP:RNA complex was sampled by all-atom classical MD simulations. In particular in the following we describe the interaction network, leading to a stable protein/nucleic acid complex, as well as the main structural deformations experienced by the RNA strand and the enzymatic site. Importantly, to assure the accuracy of the viral replication RNAP relies on the Watson and Crick coupling between a nascent RNA strand and its original template. Hence, the nucleic acid needs to assume a double-stranded secondary structure, while its precise tertiary folding is largely dictated by the interaction with the RNAP interface.

At the interface between the nucleic acid and the enzyme, basic and polar amino acids develop non-specific contact with the RNA backbone leading to a dense interaction network.

The rather unspecific binding of RNA and DNA through electrostatic interactions with the negative backbone is common among different nucleic acid processing or compacting proteins, including endonucleases or histone-like agents.

On Interestingly, the interaction between the double-strand nucleic acid and the enzyme, leading to a contact region spanning from base pair 5 to 9, is also translated into a rigidification and stabilization of the RNA. Indeed, the structural parameters of the RNA base-pairs as computed with Curves+ indicate a very stable and mostly ideal conformation of the double strand when in contact with the polymerase interface. This observation is most probably due to highly dense interaction network involving strong electrostatic interactions as abovedescribed. Concerning the global structural descriptors of duplex RNA, the bending remains low for the base-pairs buried in the protein (up to 3.6 ± 2.2 • for bp 5), while the regions more exposed to the solvent experience a higher flexibility with the local bending reaching 6.8 ± 6.7 • for bp 2 -see Table 1 . This behavior is also reflected in the systematically higher deviations of the axis parameters for the regions of the double strand which are more exposed to the water bulk -see Figure S3 . Overall, the protein embedding stabilizes and rigidifies the RNA duplex structure, hence assuring the Watson and Crick coupling and offering an appro- Figure 3 : Main interactions between the enzyme (residues with blue carbon atoms) and A) the RNA template strand or B) the RNA nascent strand. The RNA strands are depicted in red and the protein structure appears in light grey. C) Zoom on the interaction of the key-residue S682 with the nucleotide to be integrated (GTP) and the facing rC12 on the template strand. D) Distribution of the distances between S682 and the base pair that is about to be formed.

priate organization of the active site for the efficient incorporation of the reacting nucleotides into the nascent strand. As concerns the local organization of the active site, a first magnesium ion coordinates to D760, D618, the GTP reactive phosphate group (OP1), and the terminal deprotonated O3' of the nascent RNA strand. This interaction clearly helps in maintaining the reactive moieties ideally placed for the reaction to take place -see capable of assuming this role, the evolution of the MD simulation reveals that a proton donor, namely K551, is rapidly approaching the pyrophosphate leaving group, and is then stabilized in this conformation. K551 is not directed towards the active site in the crystal structure of RNAP with Favipiravir, however when the ligand is mutated to GTP a reorganization takes place in which K551 forms strong hydrogen bonds with the pyrophosphate group (K551:HZ2-GTP:O2G at 1.74Å). Therefore we may hypothesize that K551 may compensate for the absence of the histidine, which, in turn, suggest an important role of this residue in SARS-CoV-2 RNA polymerase enzymatic mechanism. This hypothesis will be further confirmed also by our QM/MM simulations. Of note, this lysine is highly conserved in other viral polymerase, hence suggesting a conserved biological role of this residue -see Figure S4 . Importantly the main characteristic of the active site of RNAP in complex with GTP are also retained during the QM/MM equilibration, in which only slightly adaptation of the Mg-Mg distance can be pointed out.

The free energy profile of the enzymatic reaction catalyzed by RNAP was obtained to precisely quantify the associated activation energy and driving force. The common reaction mechanism for polymerases is based on a two-steps process: i) the activation of the 3' nucleotide of the nascent strand through its deprotonation, also coupled with the protonation of the leaving pyrophosphate group -see The 2D free energy surface along ξ and χ is reported in Figure 4 -A, together with representative snapshots of critical points of the surface (4-B) . The reaction exhibits a classical nucleophilic substitution mechanism, going from the reactant (R) to the product (P) through a transition state (TS) without any intermediate. The TS is accessed bypassing only a moderate to low activation barrier ∆G ̸ = of 10 kcal/mol, hence confirm the efficiency of RNAP.

Additionally, the TS exhibits a perfectly ideal planar reacting phosphate group, which is also equidistant from O3' and O3A (1.9Å), as can be appreciated from the evolution of the distance and the phosphate pyramidalisation angle reported in Figure 4 -B and C. From a thermodynamic point of view, the reaction is found to be exergonic, with a driving force of ∆G 0 =18 kcal/mol. Upon reaching the TS, the distance between the catalytic Mg 2+ ions is slightly increased from 4.2Å to 4.8Å. The first ion maintains its interaction with D760 and D618, but not anymore with the rU9:O3' which is no longer accessible and is instead coordinated to the phosphate's oxygen of the newly incorporated guanine monophosphate.

The second ion also interacts with the the backbone of the new 3' nucleotide, D168, and one end of the pyrophosphate.

Interestingly, while the proton transfer from K551 to the pyrophosphate does not appear to be required for the completion of the reaction, as can be appreciated by the topology of the free energy surface, and by the fact that the minimum energy path lays around values of χ=0.7Å. However, the role of K551 is crucial as it induces an important stabilization of the reaction product. Interestingly, the lysine proton is much more labile in the product region, and, in shark contrast with the reactants, the presence of a large low-energy basin spanning values of χ comprised between -0.6 and 1.0Å should be highlighted. Hence, once the nucleotide is incorporated into the nascent strand, K551 is able to partially share its proton with the leaving pyrophosphate group facilitating its departure. This peculiar topology of the free energy surface, also confirms the different nature of RNAP enzymatic reactions.

Indeed, the absence of the histidine precludes the possibility of a proton-shuttle mechanism, however a lysine, in this case K551, may act as a partial proton donor leading to a product region in which the additional charge is largely delocalized over different moieties. To the best of our knowledge, this peculiar mechanism has not been identified in other polymerases, and shows how unusual active sites may lead to highly efficient turnovers. 

The following information are available free of charge. Parameters and parameterization procedure used to define the non-standard nucleic bases used in this study. Representation of the atoms in the QM partition. Additional structural parameters for the RNA double strand obtained using Curves+. Movie extracted from the US simulation representing the structural evolution during the polymerase reaction.

COVID-19: The first documented coronavirus pandemic in history

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

COVID-19): A literature review

On the origin and continuing evolution of SARS-CoV-2. National Science Review

A novel coronavirus from patients with pneumonia in China

Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: A national observational study for the Getting It Right First Time Programme

COVID-19 mortality with regard to healthcare services availability, health risks, and socio-spatial factors at department level in France: A spatial cross-sectional analysis

Infection fatality ratio and case fatality ratio of COVID-19

Origin and evolutionary analysis of the SARS-CoV-2 Omicron variant

Winter of Omicron-The Evolving COVID-19 Pandemic

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Covid-19 mRNA Vaccines -Six of One, Half a Dozen of the Other

Immunological mechanisms of vaccineinduced protection against COVID-19 in humans

COVID-19 vaccines: where we stand and challenges ahead

Characteristics of SARS-CoV-2 and COVID-19

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

The Architecture of SARS-CoV-2 Transcriptome

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands

The SARS-CoV-2 main protease as drug target. Bioorganic and Medicinal Chemistry Letters 2020

Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale Methods

Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches

Structure of replicating SARS-CoV-2 polymerase

Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design

Activation of the SARS-CoV-2 NSP14 3-5 exoribonuclease by NSP10 and response to antiviral inhibitors

Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme

Inhibition of sars-cov-2 polymerase by nucleotide analogs from a singlemolecule perspective

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

Remdesivir for the Treatment of Covid-19 -Final Report

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

Effectiveness of favipiravir in COVID-19: a live systematic review

RNA-dependent RNA polymerase in the presence of favipiravir-RTP

Computational simulation strategies for analysis of multisubunit RNA polymerases

Scalable molecular dynamics with NAMD

Scalable molecular dynamics on CPU and GPU architectures with NAMD

Generating efficient quantum chemistry codes for novel architectures

An extensible interface for QM/MM molecular dynamics simulations with AMBER

VMD: visual molecular dynamics

Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K

Refinement of the Cornell et al. Nucleic acids force field based on reference quantum chemical calculations of glycosidic torsion profiles

Upgraded AM-BER Force Field for Zinc-Binding Residues and Ligands for Predicting Structural Properties and Binding Affinities in Zinc-Proteins

Very fast prediction and rationalization of pKa values for protein-ligand complexes

Long-time-step molecular dynamics through hydrogen mass repartitioning

Particle mesh Ewald: An <i>N</i> log( <i>N</i> ) method for Ewald sums in large systems

Conformational analysis of nucleic acids revisited: Curves+

Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections

Contracted Gaussian basis sets for molecular calculations. I. Second row atoms, Z =11-18

An implementation of WHAM: the weighted histogram analysis method